30.12.2014 Views

rapporto attivita - Istituto di Ricerche Farmacologiche Mario Negri

rapporto attivita - Istituto di Ricerche Farmacologiche Mario Negri

rapporto attivita - Istituto di Ricerche Farmacologiche Mario Negri

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IRFMN<br />

Khan I A, Lupi M, Campbell L, Chappell S C, Brown M, Wiltshire M, Smith P J, Ubezio P, Errington R J<br />

Interoperability of time series cytometric data: a cross platform approach for modeling tumor heterogeneity<br />

Cytometry A 2011 79A : 214-226<br />

Labianca R, Sobrero A, Isa L, Cortesi E, Barni S, Nicolella D, Aglietta M, Lonar<strong>di</strong> S, Corsi D, Turci D,<br />

Beretta G D, Fornarini G, Dapretto E, Floriani I, Zaniboni A, GISCAD<br />

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial<br />

Ann Oncol 2011 22 : 1236-1242<br />

Goss C, Mosconi P, Renzi C, Deledda G<br />

Participation of patients and citizens in healthcare decisions in Italy<br />

Z Evid Fortbild Qual Gesundhwes 2011 105 : 277-282<br />

Canta A, Chiorazzi A, Carozzi V, Meregalli C, Oggioni N, Sala B, Crippa L, Avezza F, Forestieri D,<br />

Rotella G, Zucchetti M, Cavaletti G<br />

In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin)<br />

Cancer Chemother Pharmacol 2011 68 : 1001-1008<br />

Fruscio R, Garbi A, Parma G, Lissoni A A, Garavaglia D, Bonazzi C M, Dell'Anna T, Mangioni C,<br />

Milani R, Colombo N<br />

Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer<br />

J Natl Cancer Inst 2011 103 : 347-351<br />

Rizzi F, Pizzuto M, Lodetti L, Corli O, Da Col D, Damiani M E, Mihali D, Piva L, Saita L, Vinci M,<br />

Bonal<strong>di</strong> A, Milan Palliative Care Group Investigators<br />

Quality for home palliative care: an Italian metropolitan multicentre JCI-certified model<br />

BMJ Qual Saf Health Care 2011 20 : 592-598<br />

Pinto C, Di Fabio F, Maiello E, Pini S, Latiano T, Aschele C, Garufi C, Bochicchio A, Rosati G, Aprile<br />

G, Giaquinta S, Torri V, Bardelli A, Gion M, Martoni A<br />

Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent ra<strong>di</strong>otherapy as preoperative treatment in<br />

high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)<br />

Ann Oncol 2011 22 : 2424-2430<br />

Nal<strong>di</strong>ni A, Morena E, Belotti D, Carraro F, Allavena P, Giavazzi R<br />

Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine<br />

networks<br />

Thromb Haemost 2011 106 : 705-711<br />

Truccolo I, Bogliolo A, Ricci R, Giacomini M, Pivetti S, Russell-Edu W, De Lorenzo F, Della Seta M,<br />

Colombo Cinzia, Bufalino R, Bocchini G, Pierotti M, Lombardo C, De Paoli P<br />

CIGNOweb.it<br />

Tumori 2011 97 : 133-135<br />

Ruffini F, Failla C M, Orecchia A, Bani M R, Dorio A S, Fortes C, Zambruno G, Graziani G, Giavazzi R,<br />

D'Atri S, Lacal P M<br />

Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour<br />

progression<br />

Br J Dermatol 2011 164 : 1061-1070<br />

Lovejoy K S, Serova M, Bieche I, Emami S, D'Incalci M, Broggini M, Erba E, Gespach C, Cvitkovic E,<br />

Faivre S, Raymond E, Lippard S J<br />

Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in<br />

human cancer cells<br />

Mol Cancer Ther 2011 10 : 1709-1719<br />

36<br />

RAPPORTO ATTIVITA’ 2011

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!